- Filed
- Aug 6, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Jul 15, 2021 | 1.09B sh |
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 1.15B sh |
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 1.15B sh |
| Shares Diluted restated | Q2 2021 · Jun 30, 2020 | 956.9M sh |
| Shares Diluted restated | Q2 2021 · Jun 30, 2020 | 954.7M sh |
| Capex | Q2 2021 · Jun 30, 2021 | $4.3M |
| Capex restated | Q2 2021 · Jun 30, 2020 | $11.5M |
| Operating Cash Flow | Q2 2021 · Jun 30, 2021 | −$2.7M |
| Operating Cash Flow restated | Q2 2021 · Jun 30, 2020 | $110M |
| Long Term Debt | Q2 2021 · Jun 30, 2021 | $1.32B |
| Long Term Debt | Q2 2021 · Dec 31, 2020 | $1.29B |
| Short Term Investments | Q2 2021 · Jun 30, 2021 | $444.5M |
| Short Term Investments | Q2 2021 · Dec 31, 2020 | $208.4M |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $1.06B |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $1.36B |
| Stockholders Equity | Q2 2021 · Jun 30, 2021 | $3.02B |
| Stockholders Equity | Q2 2021 · Mar 31, 2021 | $2.94B |
| Stockholders Equity | Q2 2021 · Dec 31, 2020 | $2.94B |
| Stockholders Equity restated | Q2 2021 · Jun 30, 2020 | $1.74B |
| Stockholders Equity restated | Q2 2021 · Mar 31, 2020 | $1.86B |
| Stockholders Equity restated | Q2 2021 · Dec 31, 2019 | $1.98B |
| Current Liabilities | Q2 2021 · Jun 30, 2021 | $1.51B |
| Current Liabilities | Q2 2021 · Dec 31, 2020 | $1.33B |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $3.11B |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $3.27B |
| Current Assets | Q2 2021 · Jun 30, 2021 | $1.98B |
| Current Assets | Q2 2021 · Dec 31, 2020 | $1.86B |
| Total Assets | Q2 2021 · Jun 30, 2021 | $6.13B |
| Total Assets | Q2 2021 · Dec 31, 2020 | $6.21B |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | $0.02 |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | $0.00 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | −$0.16 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | −$0.27 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | $0.03 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | $0.00 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | −$0.16 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | −$0.27 |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $37.9M |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $73.6M |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $39.2M |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $67.4M |
| Rd Expense | Q2 2021 · Jun 30, 2021 | $109.8M |
| Rd Expense | Q2 2021 · Jun 30, 2021 | $250.5M |
| Rd Expense restated | Q2 2021 · Jun 30, 2020 | $227.9M |
| Rd Expense restated | Q2 2021 · Jun 30, 2020 | $425.8M |
| Net Income | Q2 2021 · Jun 30, 2021 | $27.8M |
| Net Income | Q2 2021 · Jun 30, 2021 | $4.8M |
| Net Income | Q2 2021 · Mar 31, 2021 | −$23M |
| Net Income | Q2 2021 · Jun 30, 2020 | −$150.3M |
| Net Income restated | Q2 2021 · Jun 30, 2020 | −$254.2M |
| Net Income restated | Q2 2021 · Mar 31, 2020 | −$103.9M |
| Operating Income | Q2 2021 · Jun 30, 2021 | $74.8M |
| Operating Income | Q2 2021 · Jun 30, 2021 | $69.3M |
| Operating Income restated | Q2 2021 · Jun 30, 2020 | −$129.3M |
| Operating Income restated | Q2 2021 · Jun 30, 2020 | −$221M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $253.3M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $514M |
| Cost Of Revenue restated | Q2 2021 · Jun 30, 2020 | $179.2M |
| Cost Of Revenue restated | Q2 2021 · Jun 30, 2020 | $325.4M |
| Revenue | Q2 2021 · Jun 30, 2021 | $720M |
| Revenue | Q2 2021 · Jun 30, 2021 | $1.4B |
| Revenue restated | Q2 2021 · Jun 30, 2020 | $451.7M |
| Revenue restated | Q2 2021 · Jun 30, 2020 | $855.4M |